1
|
Ogle GD, Wang F, Haynes A, Gregory GA, King TW, Deng K, Dabelea D, James S, Jenkins AJ, Li X, Ma RCW, Maahs DM, Oram RA, Pihoker C, Svensson J, Zhou Z, Magliano DJ, Maniam J. Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Res Clin Pract 2025; 225:112277. [PMID: 40412624 DOI: 10.1016/j.diabres.2025.112277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2025] [Revised: 05/18/2025] [Accepted: 05/21/2025] [Indexed: 05/27/2025]
Abstract
AIMS Globally, symptomatic type 1 diabetes (T1D) prevalence varies markedly. The International Diabetes Federation 11thEdition Atlas/T1D Index Version 3.0 estimated 2025 numbers for 202 countries/territories ("countries"), and projected to2040. METHODS The T1D Index model, a Markov model with sub-models for incidence-over-time, adult incidence, and mortality-over-time, was updated with recent population-based T1D incidence, mortality and prevalence studies. For countries without studies, data were extrapolated from countries with similarsettings. RESULTS There are estimated 9.5 million people living with T1D globally (compared to 8.4 million in 2021, a 13 % increase), with 1.0 million of these aged 0-14, and 0.8 million aged 15-19 years. In lower-income countries, prevalent cases increased by 20 % from 1.8 million in 2021 to 2.1 million in 2025. Incident cases in 2025 are an estimated 513,000 (164,000 aged 0-14 and 58,000 aged 15-19 years), with incidence increasing by 2.4 % in the last year. Premature deaths are estimated at 174,000, with 17.2 % of these due to non-diagnosis soon after clinical onset. The estimated remaining life expectancy of a 10-year-old child diagnosed with T1D in 2025 varies between countries from 6 to 66 years. There are still no data available for 119 countries. The projectedT1D population for 2040 is estimated to be14.7 million. CONCLUSIONS The number of global T1D cases is rising quickly, especially in lower-income settings, due to increasing diagnosed incidence, falling mortality and ageing, and population growth. Contemporary data are unavailable for over 50% of all countries, highlighting need for epidemiological studies.
Collapse
Affiliation(s)
- Graham D Ogle
- Life for a Child, Diabetes Australia, 26 Arundel St, Glebe, New South Wales 2031, Australia; Sydney Medical School, University of Sydney, Camperdown, New South Wales 2050, Australia.
| | - Fei Wang
- Global Responsibility Department, Breakthrough T1D, 200 Vesey St NE, NY, United States.
| | - Aveni Haynes
- Life for a Child, Diabetes Australia, 26 Arundel St, Glebe, New South Wales 2031, Australia.
| | - Gabriel A Gregory
- Life for a Child, Diabetes Australia, 26 Arundel St, Glebe, New South Wales 2031, Australia.
| | - Thomas W King
- Global Responsibility Department, Breakthrough T1D, 200 Vesey St NE, NY, United States.
| | - Kylie Deng
- Global Responsibility Department, Breakthrough T1D, 200 Vesey St NE, NY, United States.
| | - Dana Dabelea
- Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, 13001 East 17th Place, Aurora 80045 CO, United States.
| | - Steven James
- School of Health, University of the Sunshine Coast, 1 Moreton Bay Parade, Petrie, Queensland 4502, Australia.
| | - Alicia J Jenkins
- Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia.
| | - Xia Li
- National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha 410011 Hunan, China; Key Laboratory of Diabetes Immunology, (Central South University), Ministry of Education, Changsha 410011 Hunan, China; Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011 Hunan, China.
| | - Ronald C W Ma
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, The Chinese University Of Hong Kong Central Ave, Hong Kong; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, The Chinese University Of Hong Kong Central Ave, Hong Kong.
| | - David M Maahs
- Department of Pediatrics and Health Research and Policy, Epidemiology, Stanford University, 279 Campus Dr, Stanford, CA 94305, United States.
| | - Richard A Oram
- Clinical and Biomedical Science, University of Exeter, Exeter, United Kingdom.
| | - Catherine Pihoker
- Department of Pediatrics, University of Washington, 1410 NE Campus Parkway, Seattle, WA 98195, United States.
| | - Jannet Svensson
- Department of Clinical and Translational Research, Steno Diabetes Center Borgmester Ib Juuls Vej 83, 2730 Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medicine, University of Copenhagen, Copenhagen, Denmark.
| | - Zhiguang Zhou
- National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha 410011 Hunan, China; Key Laboratory of Diabetes Immunology, (Central South University), Ministry of Education, Changsha 410011 Hunan, China; Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011 Hunan, China.
| | - Dianna J Magliano
- Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia; School of Public Health and Preventive Medicine, Monash University, 21 Chancellor's Walk, Clayton Victoria 3800, Australia.
| | - Jayanthi Maniam
- Life for a Child, Diabetes Australia, 26 Arundel St, Glebe, New South Wales 2031, Australia; University of New South Wales, UNSW, High St, Kensington NSW 2052, Australia
| |
Collapse
|
2
|
Zhang Y, Liu X, Yang S, Yang X, Shang M, Zhang Y, Tian L. Incidence of type 1 diabetes in Gansu Province, Northwest China from 2018 to 2022: a multicenter, hospitalization-based study. Acta Diabetol 2024:10.1007/s00592-024-02427-6. [PMID: 39671115 DOI: 10.1007/s00592-024-02427-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2024] [Accepted: 11/23/2024] [Indexed: 12/14/2024]
Abstract
OBJECTIVE To survey the epidemiology of type 1 diabetes in all age groups living in the Gansu Province, China during 2018-2022. METHODS Using the data from the Gansu Province Health Commission Information Center and medical records, the crude incidence and 95%CI were calculated by region, age group, and sex assuming a Poisson distribution. The incidence differences were evaluated using the χ2 test. Spearman correlation was used to analyze the relation between latitude and incidence. The seasonality was analyzed using concentration, seasonal index and circular distribution method. RESULTS 1393 cases of newly diagnosed type 1 diabetes were ascertained. The crude incidence of type 1 diabetes per 100,000 person-years in all individuals in Gansu Province was 1.09(95% confidence interval 1.03 to 1.15). The estimated incidence per 100,000 person-years by age group was 1.39 (95%CI:1.24-1.54) for 0-14 years, 3.58 (95%CI:3.33-3.83) for 15-29 years, 0.33(95%CI:0.29-0.37) for ≥ 30 years, with a peak in age group 15-19 years. There was a difference between males and females. Incidence of type 1 diabetes in Gansu Province was strongly correlated with latitude among children aged 0-29 years, and all age groups, but such correlation was not observed in adults aged ≥ 30 years. The seasonality of the type 1 diabetes is not obvious. CONCLUSION The incidence of type 1 diabetes was relatively lower from 2018 to 2022 in Gansu Province, with variations across different regions and a positive correlation with latitude observed in all age groups. The incidence peak was noted in the 15-19 years group, and the incidence among males was higher than in females in all age groups. There was no significant seasonal variation in the incidence of type 1 diabetes.
Collapse
Affiliation(s)
- Yue Zhang
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, China
- Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, 730000, China
- Clinical Research Center for Metabolic Diseases, Lanzhou, 730000, Gansu Province, China
| | - Xiaoning Liu
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China
| | - Shaolun Yang
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China
| | - Xueni Yang
- Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, 730000, China
- Clinical Research Center for Metabolic Diseases, Lanzhou, 730000, Gansu Province, China
- The First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China
| | - Mengmeng Shang
- Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, 730000, China
- Clinical Research Center for Metabolic Diseases, Lanzhou, 730000, Gansu Province, China
- The First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China
| | - Yujie Zhang
- Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, 730000, China
- Clinical Research Center for Metabolic Diseases, Lanzhou, 730000, Gansu Province, China
- The First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China
| | - Limin Tian
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, China.
- Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, 730000, China.
- Clinical Research Center for Metabolic Diseases, Lanzhou, 730000, Gansu Province, China.
| |
Collapse
|
3
|
王 晓, 龚 爱, 齐 晟, 刘 兰. [Risk factors for ketoacidosis in children/adolescents with type 1 diabetes mellitus and establishment of a predictive model]. ZHONGGUO DANG DAI ER KE ZA ZHI = CHINESE JOURNAL OF CONTEMPORARY PEDIATRICS 2024; 26:62-66. [PMID: 38269461 PMCID: PMC10817738 DOI: 10.7499/j.issn.1008-8830.2308042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Accepted: 10/31/2023] [Indexed: 01/26/2024]
Abstract
OBJECTIVES To investigate the risk factors for diabetic ketoacidosis (DKA) in children/adolescents with type 1 diabetes mellitus (T1DM) and to establish a model for predicting the risk of DKA. METHODS A retrospective analysis was performed on 217 children/adolescents with T1DM who were admitted to General Hospital of Ningxia Medical University from January 2018 to December 2021. Among the 217 children/adolescents,169 cases with DKA were included as the DKA group and 48 cases without DKA were included as the non-DKA group. The risk factors for DKA in the children/adolescents with T1DM were analyzed, and a nomogram model was established for predicting the risk of DKA in children/adolescents with T1DM. RESULTS For the 217 children/adolescents with T1DM, the incidence rate of DKA was 77.9% (169/217). The multivariate logistic regression analysis showed that high levels of random blood glucose, hemoglobin A1c (HbA1c), blood ketone body, and triglyceride on admission were closely associated with the development of DKA in the children/adolescents with T1DM (OR=1.156, 3.2031015, 20.131, and 9.519 respectively; P<0.05). The nomogram prediction model had a C-statistic of 0.95, with a mean absolute error of 0.004 between the risk of DKA predicted by the nomogram model and the actual risk of DKA, indicating that the model had a good overall prediction ability. CONCLUSIONS High levels of random blood glucose, HbA1c, blood ketone body, and triglyceride on admission are closely associated with the development of DKA in children/adolescents with T1DM, and targeted intervention measures should be developed to reduce the risk of DKA.
Collapse
|
4
|
Li Y, Qian K, Wu D, Wang X, Cui H, Yuan G, Yuan J, Yang L, Wei L, Cao B, Su C, Liang X, Liu M, Li W, Qin M, Chen J, Meng X, Wang R, Su S, Chen X, Chen H, Gong C. Incidence of Childhood Type 1 Diabetes in Beijing During 2011-2020 and Predicted Incidence for 2025-2035: A Multicenter, Hospitalization-Based Study. Diabetes Ther 2023; 14:519-529. [PMID: 36701106 PMCID: PMC9879256 DOI: 10.1007/s13300-023-01367-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Accepted: 01/09/2023] [Indexed: 01/27/2023] Open
Abstract
INTRODUCTION China has a low incidence of type 1 diabetes mellitus (T1DM); however, based on the large population, the absolute numbers are high. Our aim was to assess the incidence of childhood T1DM in Beijing during 2011-2020, predicted incidence for 2025-2035, and to determine the incidence of diabetic ketosis or diabetic ketoacidosis (DK/DKA) in this population. METHODS Data on patients aged less than 15 years of age with newly diagnosed T1DM between January 1, 2011 and December 31, 2020 was obtained from five tertiary hospitals in Beijing and retrospectively analyzed. RESULTS In all, 636 children aged less than 15 years were diagnosed with T1DM during 2011-2020. The incidence of T1DM was 3.11-5.46 per 100,000 per year, with an average increase of 5.10% per year. The age-specific incidence for ages 0-4 years, 5-9 years, and 10-14 years was 2.97, 4.69, and 4.68 per 100,000 per year, respectively. The highest average annual increase (7.07%) in incidence was for the youngest age group. DK or DKA was present at the time of diagnosis of T1DM in 84.6% of patients. The age-specific incidence of T1DM among children aged less than 15 years was predicted to be 7.32, 11.4, and 11.52 per 100,000 in 2035 for ages 0-4 years, 5-9 years, and 10-14 years, respectively. CONCLUSIONS The was a gentle increase in the incidence of childhood T1DM during 2011-2020 in Beijing. This increase is expected to continue for the next 15 years.
Collapse
Affiliation(s)
- Yuchuan Li
- Outpatient Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China
| | - Kun Qian
- Department of Endocrinology, Capital Institute of Pediatrics, No. 2 Yaobao Road Chaoyang District, Beijing, 100020, China
| | - Di Wu
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Xinli Wang
- Department of Pediatrics, Third Hospital Peking University, Beijing, 100191, China
| | - Hong Cui
- Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China
| | - Geheng Yuan
- Department of Endocrinology, Peking University First Hospital, Beijing, 100034, China
| | - Jinfang Yuan
- Department of Pediatrics, Third Hospital Peking University, Beijing, 100191, China
| | - Lijun Yang
- Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China
| | - Liya Wei
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Bingyan Cao
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Chang Su
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Xuejun Liang
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Min Liu
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Wenjing Li
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Miao Qin
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Jiajia Chen
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Xi Meng
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Rui Wang
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Shan Su
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China
| | - Xiaobo Chen
- Department of Endocrinology, Capital Institute of Pediatrics, No. 2 Yaobao Road Chaoyang District, Beijing, 100020, China.
| | - Hui Chen
- School of Biomedical Engineering, Capital Medical University, No. 10 Youanmenwai Xitoutiao, Fengtai District, Beijing, 100069, China.
| | - Chunxiu Gong
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Xicheng District, Beijing, 100045, China.
| |
Collapse
|